DAVILYN WORTHINGTON: Open Payments
NPI 1831463611 · TULSA, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$484 in 25 payments from 16 companies in 2025. Trend: 2023 $953 · 2024 $647 · 2025 $484
Food & beverage: $484
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $98 |
| Lilly USA, LLC | 3 | $53 |
| Amgen Inc. | 3 | $47 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $33 |
| Aimmune Therapeutics, Inc. | 1 | $28 |
| Novo Nordisk Inc | 1 | $27 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $25 |
| Novartis Pharmaceuticals Corporation | 1 | $24 |
| Lundbeck LLC | 1 | $23 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $21 |
Products named: AIRSUPRA, JARDIANCE, Kerendia, EVENITY, ZENPEP, Ozempic, LEQVIO, REXULTI.
Industry payments across OK — which companies pay providers there.
